These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7486945)

  • 1. Levels of flurithromycin in female genital tissue.
    Furneri PM; Cianci A; Campo L; Roccasalva LS; Tempera G; Fiore G; Palumbo G; Lepore AM; Nicoletti G
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1899-901. PubMed ID: 7486945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical-physical profile of the novel macrolide antibiotic flurithromycin ethylsuccinate.
    Colombo N; Depaoli A; Gobetti M; Saorin MG
    Arzneimittelforschung; 1994 Jul; 44(7):850-5. PubMed ID: 7945521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial activity and postantibiotic effect of flurithromycin against Helicobacter pylori strains.
    Fera MT; Giannone M; Pallio S; Tortora A; Blandino G; Carbone M
    Int J Antimicrob Agents; 2001 Feb; 17(2):151-4. PubMed ID: 11165121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentrations of flurithromycin in serum and tonsils.
    Galioto GB; Mevio E; Galioto P; Zanuso G; Lepore AM
    Int J Clin Pharmacol Ther Toxicol; 1989 Mar; 27(3):126-8. PubMed ID: 2722307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of flurithromycin, a new macrolide antibiotic, on carbamazepine disposition in normal subjects.
    Barzaghi N; Gatti G; Crema F; Faja A; Monteleone M; Amione C; Leone L; Perucca E
    Int J Clin Pharmacol Res; 1988; 8(2):101-5. PubMed ID: 3378851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of flurithromycin against some genital pathogens.
    Furneri PM; Tempera G; Lepore AM; Bonfanti C; Nicoletti G
    Drugs Exp Clin Res; 1991; 17(3):175-80. PubMed ID: 1914844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and human tissue penetration of flurithromycin.
    Benoni G; Cuzzolin L; Leone R; Consolo U; Ferronato G; Bertrand C; Puchetti V; Fracasso ME
    Antimicrob Agents Chemother; 1988 Dec; 32(12):1875-8. PubMed ID: 3245699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial activity and post-antibiotic effect of flurithromycin compared with other macrolides and penicillins against periodontal pathogens.
    Lo Bue AM; Blandino G; Milazzo I; Pasquantonio G; Speciale A; Nicoletti G
    J Chemother; 2001 Jun; 13(3):255-9. PubMed ID: 11450882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioactivity of flurithromycin and other macrolides against intracellular susceptible staphylococci.
    Fietta A; Boeri P; Colombo ML; Merlini C; Gialdroni Grassi G
    Chemotherapy; 1993; 39(1):48-54. PubMed ID: 8444060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of flurithromycin ethylsuccinate in healthy volunteers.
    Cocuzza CE; Mattina R; Lanzafame A; Romoli L; Lepore AM
    Chemotherapy; 1994; 40(3):157-60. PubMed ID: 8205933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of food on the absorption of flurithromycin in man.
    Lepore AM; Bonardi G; Maggi GC
    Int J Clin Pharmacol Res; 1988; 8(4):253-7. PubMed ID: 3182114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial profile of flurithromycin, a new macrolide.
    Saverino D; Debbia EA; Pesce A; Lepore AM; Schito GC
    J Antimicrob Chemother; 1992 Sep; 30(3):261-72. PubMed ID: 1452490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Female genital tissue concentrations of roxithromycin.
    Furneri PM; Pinizzotto MR; Rugolo S; Cianci S; Cianci A; Tempera G
    J Chemother; 1991 Jan; 3 Suppl 1():30-2. PubMed ID: 12041780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steady-state plasma and intrapulmonary pharmacokinetics and pharmacodynamics of cethromycin.
    Conte JE; Golden JA; Kipps J; Zurlinden E
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3508-15. PubMed ID: 15328118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution.
    Girard AE; Girard D; English AR; Gootz TD; Cimochowski CR; Faiella JA; Haskell SL; Retsema JA
    Antimicrob Agents Chemother; 1987 Dec; 31(12):1948-54. PubMed ID: 2830841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological properties of ER 42859, a novel erythromycin derivative.
    Wilson JM; Hannan PC; Shillingford C; Knowles DJ
    J Antibiot (Tokyo); 1989 Mar; 42(3):454-62. PubMed ID: 2708138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic and intestinal effects of flurithromycin and erythromycin in the rat.
    Benoni G; Cuzzolin L; Leone R; Fracasso ME
    J Chemother; 1992 Oct; 4(5):271-5. PubMed ID: 1479415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmid-borne macrolide resistance in Micrococcus luteus.
    Liebl W; Kloos WE; Ludwig W
    Microbiology (Reading); 2002 Aug; 148(Pt 8):2479-2487. PubMed ID: 12177341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and tissue residue profiles of erythromycin in broiler chickens after different routes of administration.
    Goudah A; Abo El Sooud K; Abd El-Aty AM
    Dtsch Tierarztl Wochenschr; 2004 Apr; 111(4):162-5. PubMed ID: 15171602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of flurithromycin, a novel macrolide antibiotic.
    Gialdroni Grassi G; Alesina R; Bersani C; Ferrara A; Fietta A; Peona V
    Chemioterapia; 1986 Jun; 5(3):177-84. PubMed ID: 3487389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.